LivaNova

London, United Kingdom Founded: 2015 • Age: 11 yrs
Therapeutic devices for cardiac and neurological conditions are provided worldwide.
Request Access

About LivaNova

LivaNova is a company based in London (United Kingdom) founded in 2015.. The company has 2,900 employees as of December 31, 2024. LivaNova has completed 4 acquisitions, including ALung, Caisson International and ImThera Medical. LivaNova offers products and services including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression.

  • Headquarter London, United Kingdom
  • Employees 2900 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Livanova Plc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $1.25 B
    8.66
    as on Dec 31, 2024
  • Net Profit
    $63.23 M
    260.39
    as on Dec 31, 2024
  • EBITDA
    $216.58 M
    35.53
    as on Dec 31, 2024
  • Latest Funding Round
    $1.23 M (USD), Grant

    Jan 01, 2021

  • Investors
  • Employee Count
    2900

    as on Dec 31, 2024

  • Investments & Acquisitions
    ALung

    & 3 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of LivaNova

LivaNova is a publicly listed company on the NASDAQ with ticker symbol LIVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: LIVN . Sector: Health technology · USA

Products & Services of LivaNova

LivaNova offers a comprehensive portfolio of products and services, including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

System for supporting cardiopulmonary functions during procedures.

Device that treats drug-resistant epilepsy through nerve stimulation.

Device aimed at managing difficult-to-treat depression via stimulation.

People of LivaNova
Headcount 1000-5000
Employee Profiles 233
Board Members and Advisors 7
Employee Profiles
People
Matthew Dodds
SVP, orporate Development & IT
People
Nongnutch Jeamsirimuneewongsa
Supply Chain / Customer Service Manager - Thailand
People
Deborah Pantaleoni
Indirect Procurement Manager, Global Procurement
People
Michael Hutchinson
SVP, Chief Legal Officer & Company Secretary

Unlock access to complete

Board Members and Advisors
people
Andrea L. Saia
Director
people
Stacy Enxing Seng
Independent Director
people
Todd C. Schermerhorn
Director
people
Brooke Story
Director

Unlock access to complete

Funding Insights of LivaNova

  • Total Funding
  • Total Rounds 6
  • Last Round Grant — $1.2M
  • First Round

    (15 Dec 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Grant - LivaNova Valuation

investors

Apr, 2019 Amount Grant - LivaNova Valuation

investors

Apr, 2019 Amount Debt – Conventional - LivaNova Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in LivaNova

LivaNova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Ministry of Economic Development & Trade. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Timely advice is provided to foreign investors on economic opportunities.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by LivaNova

LivaNova has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ALung, Caisson International and ImThera Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Implantable neurostimulation devices for obstructive sleep apnea are developed.
2008
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
1997
Circulatory support devices and ventricular assist systems are provided.
1996
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - LivaNova

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Livanova Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LivaNova

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Livanova

Frequently Asked Questions about LivaNova

When was LivaNova founded?

LivaNova was founded in 2015.

Where is LivaNova located?

LivaNova is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

How many employees does LivaNova have?

As of Dec 31, 2024, the latest employee count at LivaNova is 2,900.

What is the annual revenue of LivaNova?

Annual revenue of LivaNova is $1.25B as on Dec 31, 2024.

What does LivaNova do?

LivaNova was founded in 2015 and is headquartered in London, United Kingdom. Operations focus on the medical device sector, where cardiac rhythm management and neuromodulation products are developed and distributed. Services include advanced surgical tools and monitoring systems for heart and brain therapies. Global reach is maintained through regulatory compliance and partnerships in healthcare markets, supporting clinical applications across various regions.

What products or services does LivaNova offer?

LivaNova offers Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression.

Is LivaNova publicly traded?

Yes, LivaNova is publicly traded on NASDAQ under the ticker symbol LIVN.

How many acquisitions has LivaNova made?

LivaNova has made 4 acquisitions, including ALung, Caisson International, and ImThera Medical.

Who are LivaNova's investors?

LivaNova has 2 investors. Key investors include European Union, and Ministry of Economic Development & Trade.

What is LivaNova's ticker symbol?

The ticker symbol of LivaNova is LIVN on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available